Allen Murga, MD
Vascular Surgery · Loma Linda, CANPI 1124386370
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Medtronic at 28.4% of the total.
Across 321 payments — averaging $95.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Cook Incorporated$5K
- W. L. Gore & Associates, Inc.$5K
- Cook Medical LLC$4K
- Silk Road Medical, Inc.$3K
- Endologix LLC$2K
- plus $4K from 19 others
Across 8 payments — averaging $6337.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$51K
What the payments were for
- Speaking & faculty fees$8,94029%
- Travel & lodging$5,26617%
- Food & beverage$16,54954%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 82 | $8,741 |
| Cook Incorporated | 3 | $4,940 |
| W. L. Gore & Associates, Inc. | 42 | $4,650 |
| Cook Medical LLC | 75 | $3,760 |
| Silk Road Medical, Inc. | 36 | $2,562 |
| Endologix LLC | 14 | $1,636 |
| Terumo Medical Corporation | 9 | $936 |
| Inari Medical, Inc. | 6 | $799 |
| Shockwave Medical, Inc | 13 | $749 |
| Penumbra, Inc. | 4 | $438 |
| BD | 8 | $419 |
| Bard Peripheral Vascular, Inc. | 4 | $238 |
| Bolton Medical Inc | 3 | $218 |
| Abbott | 4 | $155 |
| Organogenesis Inc. | 1 | $122 |
| Acera Surgical, Inc. | 4 | $111 |
| Johnson & Johnson | 4 | $96 |
| Baxter Healthcare | 2 | $38 |
| Mimedx Group, Inc. | 1 | $31 |
| Cvrx, Inc. | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $23 |
| Centerline Biomedical Inc. | 1 | $20 |
| Merit Medical Systems Inc | 1 | $19 |
| Smith+Nephew | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zenith Spiral-Z$3,657
- Cook$2,983
- Endurant$2,450
- ENDURANT IIS$2,270
- ENROUTE Transcarotid Neuroprotection System$2,082
- ENROUTE Transcarotid Stent$1,969
- GORE TAG Thoracic Endoprosthesis$1,853
- Valiant Captivia$1,540
- ENDOCROSS Device$1,132
- Torus Stent Graft System$1,132
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,097
- ENHANCE Transcarotid Peripheral Access Kit$734
- ENROUTE .014 Guidewire$734
- Azur CX Detachable$661
- FLOWTRIEVER CATHETER, S$653
- CT THROMBECTOMY SYSTEM KIT$653
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$526
- HawkOne$457
- GORE TAG Thoracic Branch Endoprosthesis$365
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$323
How this compares
$30,754 in reported general payments places this provider in the 85th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $17,054 |
| XareltoRivaroxaban | 13 | $9,536 |
| ClopidogrelClopidogrel Bisulfate | 51 | $464 |
| Cilostazol | 12 | $177 |
| Atorvastatin Calcium | 13 | $88 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $96 | $9,53613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 519 vascular surgery providers in California.
Other vascular surgery in Loma Linda
- Theodore TeruyaLoma Linda$43K
- Son DuongFountain Valley$503K
- Venita ChandraPalo Alto$488K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
- Johnathon RolloLos Angeles$337K
- Melissa LojaFairfield$272K
- Jason LeePalo Alto$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.